Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
Europe Medical Device Policy & Regulation

Staffing Challenges Dominate EU Medtech Regulatory Plans

  • Analysis

Executive Summary

EU Commission, competent authorities, notified bodies and industry: Everyone is struggling to find the staffing resources necessary to build the infrastructure for implementing the EU’s oncoming medtech regulations.

You may also be interested in...



EU Regs: Resource Gaps Could Threaten Existing Products, But Some Protections In Place

There is still a lack of clarity over whether notified bodies and competent authorities will find sufficient resources for the smooth implementation of the forthcoming Medical Devices and IVD Regulations. Does this mean some products considered safe today may have to be removed unnecessarily from the EU market?

New World Of Regulation Awaits IVD Companies In Europe From Coming Reforms

EU power players are currently negotiating vast changes to how in vitro diagnostics are regulated in Europe. The resulting system will involve a lot more external oversight than today for most IVDs. Here's a rundown of what to expect.

UK Responsible Person, EU ARs and Northern Ireland: The View From MedTech Europe

Table

View full table

Topics

Tags:
Europe Medical Device Policy & Regulation
UsernamePublicRestriction

Register

LL016481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By